Explorer les evidences

32 %During the last 3 months of the trial, 32% of family planning clients were tested for HIV at control clinics in Mombasa, Kenya.

KenyaVIH/sidapublié 2022AIDS (London, England)europe_pmcdocument de 3 observations

0 seroconversionsNo HIV seroconversions were observed over the follow-up period.

KenyaVIH/sidapublié 2023JAMA network openPubMeddocument de 9 observations

19 %19% of women living with HIV agreed with at least three internalized stigma statements, indicating medium/high levels of internalized stigma.

KenyaVIH/sidaobservé 2015 to 2017publié 2021BMC women's healthPubMeddocument de 7 observations

1,56 aHRDepot medroxyprogesterone acetate (DMPA) was significantly associated with elevated risk of HIV seroconversion in women with bacterial vaginosis (adjusted hazard ratio 1.56, 95% confidence interval 1.08–2.25).

Kenyavaginose bactérienne · VIH/sidaobservé 1993 to 2017publié 2019AIDS (London, England)europe_pmcdocument de 4 observationsDOI 10.1097/qad.0000000000002167

2 257 individualsFrom October 2022 to December 2023, 2257 individuals were screened and 1915 were enrolled in the ePrEP Kenya pilot.

KenyaVIH/sidaobservé October 2022 to December 2023publié 2025Journal of the International AIDS SocietyPubMeddocument de 19 observations

0 infectionsThere were no incident HIV infections in 400 person-years of follow-up in the intervention group.

KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 9 observations

96 %Of 25 participants with incident HIV infection, 24/25 (96%) started antiretroviral therapy (ART).

KenyaVIH/sidapublié 2021PLoS medicinePubMeddocument de 12 observations

15 %Adolescents comprise approximately 15% of new HIV infections in Kenya.

KenyaVIH/sidapublié 2023AIDS education and prevention : official publication of the International Society for AIDSPubMeddocument de 2 observations

2,71 odds_ratioIn a cohort of 309 adolescent girls and young women aged 15–24 years living with HIV in Kisumu County, western Kenya, substance use was associated with significantly higher odds of poor antiretroviral therapy adherence (Odds Ratio = 2.71).

KenyaVIH/sidaobservé January to June 2022publié 2023International journal of environmental research and public healthPubMeddocument de 4 observations

60 %Male circumcision provides men with approximately 60% protection from acquiring HIV infection via heterosexual sex.

KenyaVIH/sidapublié 2018BMC infectious diseaseseurope_pmcdocument de 2 observations

95 %Ninety-five percent of adolescents and young adults living with HIV were virally suppressed.

KenyaVIH/sidapublié 2026Journal of the International Association of Providers of AIDS CarePubMeddocument de 8 observations

0,9 %In a prospective study of HIV incidence in African women in Eswatini, Kenya, South Africa, and Zambia, true positive HIV results occurred at 412 visits (0.9%) out of 48,234 visits.

Afrique du Sud · Kenya · ZambieVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations

3,97 RRRHIV status was associated with higher odds of dual method use, with a ratio of relative risk of 3.97.

KenyaVIH/sidaobservé 2015 to 2016publié 2023ContraceptionPubMeddocument de 6 observations

25 %Among adolescents living with HIV (ALH) in school, 25% in day schools self-reported missing antiretroviral therapy (ART) when school was in session.

KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 14 observations

26 %In Kenya, family testing contributed 26% of the total number of children identified with HIV.

KenyaVIH/sidaobservé 2015–2016publié 2020International journal of STD & AIDSPubMeddocument de 7 observations

18 %A restrictive spirometry pattern (RSP) was observed in 18% of adolescents with HIV in Nairobi, Kenya.

KenyaVIH/sidapublié 2025ChestPubMeddocument de 9 observations

28 %Of those screened for PrEP eligibility, 28% of female sex workers (FSW) were ineligible.

KenyaVIH/sidaobservé February 2017 to December 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 13 observations

33,5 %The cumulative risk of loss to follow-up for people living with HIV prior to antiretroviral therapy initiation 12 months after enrollment was 33.5% (95% CI 33.36–33.58).

KenyaVIH/sidapublié 2020PloS onePubMeddocument de 12 observations

240 casesThere were 240 (31%, 95%CI 27 to 34%) people living with HIV with poor outcomes after 24 months.

KenyaVIH/sidapublié 2022PloS onePubMeddocument de 15 observations

68,1 %Among women with HIV in serodifferent relationships in Nairobi, Kenya who reported intimate partner violence in the past year, 68.1% reported emotional violence.

KenyaVIH/sidapublié 2022PloS onePubMeddocument de 8 observations

2,11 incidence_rate_ratioChart audits were associated with an incidence rate ratio of 2.11 for increased HIV testing among adolescents.

KenyaVIH/sidaobservé October 2015 to September 2016publié 2022AIDS carePubMeddocument de 16 observations

A randomized controlled trial is comparing home-based couples intervention and HIV self-testing for couples among pregnant women attending antenatal care clinics in two counties in southwestern Kenya.

KenyaVIH/sidapublié 2023Value in health regional issuesPubMeddocument de 10 observations

1,95 prevalence_ratioFemale sex workers originating from a high-prevalence county in Kenya had a prevalence ratio of 1.95 for living with HIV in adjusted analysis.

KenyaVIH/sidaobservé 2014 to 2017publié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations

19 %Awareness of oral HIVST was low (19%).

KenyaVIH/sidapublié 2023AIDS carePubMeddocument de 5 observations

14,2 %Among patients with underlying conditions in Kenya's hospitalized COVID-19 cohort, HIV was present in 14.2%.

KenyaCOVID-19 · VIH/sidapublié 2025Global health actionPubMeddocument de 11 observations